The New Zealand Meningococcal Vaccine Strategy: a tailor-made vaccine to combat a devastating epidemic.


Sexton, K; Lennon, D; Oster, P; Crengle, S; Martin, D; Mulholland, K; Percival, T; Reid, S; Stewart, J; O'Hallahan, J; (2004) The New Zealand Meningococcal Vaccine Strategy: a tailor-made vaccine to combat a devastating epidemic. The New Zealand medical journal, 117 (1200). U1015. ISSN 0028-8446

Full text not available from this repository.

Abstract

: The New Zealand Meningococcal Vaccine Strategy aims to end the devastating 14-year epidemic of B:4:P1.7b,4 group B meningococcal disease in New Zealand through a mass immunisation programme to all under 20 year olds using a tailor-made vaccine (MeNZB). This paper describes the scientific rationale, development, and key components of the New Zealand Meningococcal Vaccine Strategy. A summary of the efficacy and safety data of existing outer membrane vesicle group B meningococcal vaccines is included as these data critically support the Strategy.<br/>

Item Type: Article
Faculty and Department: Faculty of Epidemiology and Population Health > Dept of Infectious Disease Epidemiology
Research Centre: Centre for Maternal, Reproductive and Child Health (MARCH)
Vaccine Centre
PubMed ID: 15475985
URI: http://researchonline.lshtm.ac.uk/id/eprint/13084

Statistics


Download activity - last 12 months
Downloads since deposit
0Downloads
315Hits
Accesses by country - last 12 months
Accesses by referrer - last 12 months
Additional statistics for this record are available via IRStats2

Actions (login required)

Edit Item Edit Item